Lexicon Pharmaceuticals
LXRX
#7435
Rank
NZ$0.73 B
Marketcap
NZ$2.03
Share price
-0.85%
Change (1 day)
58.82%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): NZ-$0.34

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.33. In 2024 the company made an earnings per share (EPS) of NZ-$1.11 an increase over its 2023 EPS that were of NZ-$1.39.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.34-69.8%
2024NZ-$1.11-20%
2023NZ-$1.3931.15%
2022NZ-$1.06-0%
2021NZ-$1.0610.91%
2020NZ-$0.96-145.08%
2019NZ$2.12-206.09%
2018NZ-$2.00-5.74%
2017NZ-$2.12-10.95%
2016NZ-$2.382640%
2015NZ-$0.08684-96.34%
2014NZ-$2.37-2.53%
2013NZ-$2.43-9.09%
2012NZ-$2.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
NZ-$133.22 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$75.44-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$10.32 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.72-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$30.11-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.87 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.76-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$4.15-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.30 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA